Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 101   

Articles published

THRX 16.45 +0.24 (1.48%)
price chart
Theravance: 2 Hidden Catalysts Will Boost Sales
Further progress of VI monotherapy (currently in Phase III). The availability of VI monotherapy (likely in different dosages) will further enhance possible combinations with other GSK and/or THRX products.
Theravance, Inc. Appoints Eric d'Esparbes as Senior Vice President and Chief ...
SOUTH SAN FRANCISCO, CA, Oct 09, 2014 (Marketwired via COMTEX) -- Theravance, Inc. THRX, -4.32% today announced the appointment of Eric d'Esparbes as Senior Vice President and Chief Financial Officer.
Related articles »  
Theravance Inc.: Theravance Biopharma, Inc. to Report Third Quarter 2014 ...
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/30/14 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today, through its US operating subsidiary, Theravance Biopharma US, Inc., that it will ...
Related articles »  
What GSK's Q3 Results Mean For Theravance
In the reported figures there is little news: Advair is forecast to decline at similar rates as before and Anoro and Breo continue to sell below consensus.
Shining on Major News : Comcast Corporation (NASDAQ:CMCSA), Theravance ...  Tech News
Theravance to Report Third Quarter 2014 Financial Results on October 30, 2014  Marketwired (press release)
Related articles »  
Update: Why Theravance Jumped
More interesting would have been an apples-to-apples comparison between Anoro and Boehringer's investigational tiotropium + olodaterol combination.
Data Published on Anoro(R) Ellipta(R) Demonstrate Improved Lung Function ...  CNNMoney
Related articles »  
Theravance (THRX) In A Perilous Reversal
THERAVANCE INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Related articles »  
Volatile Stocks to Watch: Theravance Inc. (THRX), Endeavour Silver Corp (EXK ...
Theravance Inc. (NASDAQ:THRX) announced that it will release financial results for the period ended September 30, 2014 after market close on Thursday, October 30, 2014.
News Review -Theravance Inc(NASDAQ:THRX), American Axle & Manufact ...
Las Vegas, NV - October 31, 2014 - (TechSonian) - Theravance Inc(NASDAQ:THRX) reported financial results for the quarter ended September 30, 2014 and announced that its Board of Directors approved a $0.25 per share cash dividend to be paid on ...
Top Loser Heath Care Stocks: The Medicines Company (NASDAQ:MDCO ...
Theravance, Inc. (NASDAQ: THRX) declared the selection of Eric d'Esparbes as Senior Vice President and Chief Financial Officer.
Worst Year-To-Date Performers: Tidewater Inc. (NYSE:TDW), Theravance Inc ...
Theravance Inc (NASDAQ:THRX) has booked the year to date performance of -40.23% while its market capitalization stands at $ 2.14B.
Related articles »